1: Falagas, M. E., P. I. Rafailidis, D. K. Matthaiou, S. Virtzili, D. Nikita, and A. Michalopoulos. 2008. Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter genospecies 13 TU infections: Characteristics and outcome in a series of 28 patients. Int J Antimicrob Agents32:450-4.
2: Paterson, D. 2006. The epidemiological profile of infections with multidrug resistant Pseudomonas aeruginosa and Acinetobacter species. Clinicalinfectious diseases 43:S43-S48.
3:Giamarellou H., Antoniadou A. and Kanellakopoulou K. (2008). Acinetobacter baumannii: a universal threat to public health? Int J Antimicrob Agents, 32:106-19.
4: Fournier, P. E., and H. Richet. 2006. The epidemiology and control of Acinetobacter genospecies 13 TU in health care facilities. Clin Infect Dis42:692.
5: Zhanel, G.G., Lawson, C.D., Adam, H., Schweizer, F., Zelenitsky, S., Lagace-Wiens, P.R., Denisuik, A., Rubinstein, E., Gin, A.S., et al,( 2013). Ceftazidime–avibactam: a novel cephalosporin/beta-lactamase inhibitor combination. Drugs 73, 159–177.
6: Ting, C., Jun, A., Shun, Z.,( 2013). Detection of the common resistance genes in Gram-negative bacteria using gene chip technology. Indian.
7: Rezaee, M.A., Pajand, O., Nahaei, M.R., Mahdian, R., Aghazadeh, M., Ghojazadeh, M., Hojabri, Z., (2013). Prevalence of Ambler class A beta-lactamases and ampC expression in cephalosporin-resistant isolates of Acinetobacter baumannii. Diagn. Microbiol. Infect. Dis. 76, 330–334.
8: Peymani, A., Nahaei, M.R., Farajnia, S., Hasani, A., Mirsalehian, A., Sohrabi, N., Abbasi, L.,( 2011). High prevalence of metallo-beta-lactamase-producing Acinetobacter baumannii in a teaching hospital in Tabriz, Iran. Jpn. J. Infect. Dis. 64, 69–71.
9: Shahcheraghi, F., Abbasalipour, M., Feizabadi, M., Ebrahimipour, G., Akbari, N.,( 2011). Isolation and genetic characterization of metallo-beta-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran. J. Microbiol. 3, 68–74.
10: Pfeifer, Y., Cullik, A., Witte, W., (2010). Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int. J. Med. Microbiol. 300, 371–379.
11: Kim, Y., et al. (2014). "In vivo emergence of colistin resistance in Acinetobacter baumannii clinical isolates of sequence type 357 during colistin treatment." Diagnostic Microbiology and Infectious Disease 79(3): 362-366.